These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 34385203)

  • 21. Cutaneous manifestations of COVID-19: A review of the published literature.
    Elmas ÖF; Demirbaş A; Özyurt K; Atasoy M; Türsen Ü
    Dermatol Ther; 2020 Jul; 33(4):e13696. PubMed ID: 32458546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemic.
    Ică OM; Mitroi G; Ianoşi SL; Tutunaru CV; Leru PM; Matei D; Avramescu ET; Tănasie CA; Mitroi IB; Neagoe CD; Cazacu SM
    Rom J Morphol Embryol; 2023; 64(3):291-304. PubMed ID: 37867347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Occupational Dermatoses in Healthcare Workers during the COVID-19 Pandemic: A Narrative Review].
    Vasques AI; Ochoa-Leite C; Ramos Rocha D; Bento J; Rocha L
    Acta Med Port; 2022 Nov; 35(11):830-834. PubMed ID: 35766244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges of COVID-19 pandemic for dermatology.
    Wollina U
    Dermatol Ther; 2020 Sep; 33(5):e13430. PubMed ID: 32314460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 with dermatologic manifestations and implications: An unfolding conundrum.
    Almutairi N; Schwartz RA
    Dermatol Ther; 2020 Sep; 33(5):e13544. PubMed ID: 32385869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: A systematic review of articles.
    Molaee H; Emadi SN; M Imunya JMN; Davoudi-Monfared E; Mohammed A; Razavi Z
    Dermatol Ther; 2022 Mar; 35(3):e15298. PubMed ID: 34981615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global impact on dermatology practice due to the COVID-19 pandemic.
    Bhargava S; Negbenebor N; Sadoughifar R; Ahmad S; Kroumpouzos G
    Clin Dermatol; 2021; 39(3):479-487. PubMed ID: 34518007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cutaneous Manifestations Associated with COVID-19: A Narrative Review].
    Relvas M; Calvão J; Oliveira R; Cardoso JC; Gonçalo M
    Acta Med Port; 2021 Feb; 34(2):128-136. PubMed ID: 33315008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Cutaneous Manifestations of COVID-19: A Review of Emerging Literature.
    Enitan AO; Olasode OA
    West Afr J Med; 2020 Oct; 37(5):569-573. PubMed ID: 33058134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group.
    Larenas-Linnemann D; Luna-Pech J; Navarrete-Rodríguez EM; Rodríguez-Pérez N; Arias-Cruz A; Blandón-Vijil MV; Del Rio-Navarro BE; Estrada-Cardona A; Onuma-Takane E; Pozo-Beltrán CF; Valencia-Herrera AM; Ortiz-Aldana FI; Toledo-Bahena ME
    Curr Allergy Asthma Rep; 2021 Feb; 21(2):13. PubMed ID: 33630167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cutaneous manifestations in patients with COVID-19 with significant attention to urticaria].
    Sánchez-Borges M; González-Díaz SN; Ortega-Martell JA; Rojo-Gutiérrez MI; Ansotegui-Zubeldia IJ
    Rev Alerg Mex; 2021; 68(2):112-116. PubMed ID: 34525782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous adverse effects due to personal protective measures during COVID-19 pandemic: a study of 101 patients.
    Mushtaq S; Terzi E; Recalcati S; Salas-Alanis JC; Amin S; Faizi N
    Int J Dermatol; 2021 Mar; 60(3):327-331. PubMed ID: 33320331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A New Rash Differential: CoVID-19.
    Gooch MD
    Adv Emerg Nurs J; 2021 Jan-Mar 01; 43(1):28-34. PubMed ID: 33952873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical manifestation and disease progression in COVID-19 infection.
    Tsai PH; Lai WY; Lin YY; Luo YH; Lin YT; Chen HK; Chen YM; Lai YC; Kuo LC; Chen SD; Chang KJ; Liu CH; Chang SC; Wang FD; Yang YP
    J Chin Med Assoc; 2021 Jan; 84(1):3-8. PubMed ID: 33230062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19-specific skin changes related to SARS-CoV-2: Visualizing a monumental public health challenge.
    Schwartz RA; Lambert WC
    Clin Dermatol; 2021; 39(3):374-379. PubMed ID: 34517995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Factor Considerations in Using Personal Protective Equipment in the COVID-19 Pandemic Context: Binational Survey Study.
    Parush A; Wacht O; Gomes R; Frenkel A
    J Med Internet Res; 2020 Jun; 22(6):e19947. PubMed ID: 32511099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous manifestations related to the COVID-19 pandemic: a review article.
    Molaee H; Allahyari F; Emadi SN; Radfar S; Razavi Z
    Cutan Ocul Toxicol; 2021 Jun; 40(2):168-174. PubMed ID: 34097555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous and histopathological features of coronavirus disease 2019 in pediatrics: A review article.
    Khalili M; Iranmanesh B; Mohammadi S; Aflatoonian M
    Dermatol Ther; 2021 Jan; 34(1):e14554. PubMed ID: 33210417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 diagnosis and management: a comprehensive review.
    Pascarella G; Strumia A; Piliego C; Bruno F; Del Buono R; Costa F; Scarlata S; Agrò FE
    J Intern Med; 2020 Aug; 288(2):192-206. PubMed ID: 32348588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 and Keeping Clean: A Narrative Review To Ascertain the Efficacy of Personal Protective Equipment To Safeguard Health Care Workers Against SARS-CoV-2.
    Sud SR
    Hosp Pediatr; 2020 Jul; 10(7):570-576. PubMed ID: 32385055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.